XML 53 R43.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended
Jan. 12, 2024
Dec. 29, 2023
Jun. 02, 2023
Jan. 19, 2023
Sep. 14, 2021
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Jul. 12, 2023
Jul. 11, 2023
Jul. 10, 2023
May 12, 2023
Common stock, shares authorized           975,000,000   975,000,000 975,000,000 975,000,000 97,500,000  
Accrued bonus compensation           $ 0   $ 710,000        
Liquidation preference           The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board).            
Preferred stock value                    
Restricted Stock [Member]                        
Grants approved 50,000                      
Vest description vest annually over a 5-year period (10,000 per year) with the first vesting date of December 31, 2024 and each subsequent vesting on the one-year anniversary of the first vesting date, subject to continued employment on each applicable vesting date. vest annually over a 5-year period (10,000 per year) with the first vesting date of December 31, 2024 and each subsequent vesting on the one-year anniversary of the first vesting date, subject to continued employment on each applicable vesting date.                    
2021 Equity Incentive Plan [Member]                        
Number of additional shares authorized                   12,000,000 7,000,000  
Series V Preferred Stock [Member]                        
Liquidation preference           The distribution of Series V shares was approved and completed on June 2, 2023 to shareholders as of the record date of May 12, 2023. The Series V: (i) is non-convertible, (ii) has a 20% liquidation preference over the shares of common stock, (iii) is non-voting and (iv) has certain rights to dividends and distributions (at the discretion of the Board of Directors)            
Preferred stock value           $ 2,563,938   $ 2,563,938        
Common Stock [Member]                        
Share based payment issued           385,134 391,442          
Number of shares issued             301,154          
Preferred Stock [Member] | Series V Preferred Stock [Member]                        
Number of shares issued     14,542,803                  
Preferred stock value                       $ 2,560,000
Each Independent Director [Member]                        
Stock option grant date fair value       $ 50,000                
Each Independent Director [Member] | Four Equal Installments [Member]                        
Stock option grant date fair value       $ 12,500                
Independent Directors [Member]                        
Share based payment issued           14,206            
Officer [Member] | Common Stock [Member]                        
Share based compensation           414,148            
Accrued bonus compensation           $ 675,000            
Manish Paranjape [Member] | Restricted Stock [Member]                        
Grants approved 50,000 50,000                    
At-the-Market Offering Agreement [Member] | Wainwright And Co LLC [Member] | Maximum [Member]                        
Proceeds from issuance of common stock         $ 98,767,500              
At-the-Market Offering Agreement [Member] | H.C. Wainwright and Co., LLC [Member]                        
Percentage of gross proceeds of offerings         3.00%